Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection?

American Journal of Surgery

Volumn 193, Issue 3, 2007, Pages 319-325

  Hurtuk, M G ^a   Devata, S ^a   Brown, K M ^a   Oshima, K ^a   Aranha, G V ^a   Pickleman, J ^a   Shoup, M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Duodenal adenocarcinoma; Duodenum; Pancreas sparing duodenectomy; Pancreaticoduodenectomy; Periampullary malignancy

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EXAMINATION; DUODENUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILLINOIS; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33847076120     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.09.013     Document Type: Article

References (16)

1. Pickleman J., Koelsch M., and Chejfec G. Node-positive duodenal carcinoma is curable. Arch Surg 132 (1997) 241-244
2. Kleinerman J., Yardumian K., and Tamaki H.T. Primary carcinoma of the duodenum. Ann Intern Med 32 (1950) 451-465
3. Iovine VM, Tsangaris N. Primary carcinoma of the duodenum. Am J Surg 961;27:744-50.
4. Schmidt C.M., Powell E.S., Yiannoutsos C.T., et al. Pancreaticoduodenectomy: A 20-year experience in 516 patients. Arch Surg 139 (2004) 718-727
5. Sexe R.B., Wade T.P., Virgo K.S., et al. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer 77 (1996) 251-254
6. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226 (1997) 248-260
7. Bauer R.L., Palmer M.L., Bauer A.M., et al. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1 (1994) 183-188
8. Kaklamanos I.G., Bathe O.F., Franceschi D., et al. Extent of resection in the management of duodenal adenocarcinoma. Am J S 179 (2000) 37-41
9. Barnes G., Lucinda R., Hess K., et al. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1 (1993) 73-78
10. Maher M.M., Yeo C.J., Lillemoe K.D., et al. Pancreas-sparing duodenectomy for infra-ampullary duodenal pathology. Am J Surgery 171 (1996) 62-67
11. Alwmark A., Anderson A., and Lasson A. Primary carcinoma of the duodenum. Ann Surg 191 (1980) 13-18
12. Delcore R., Thomas J.H., Forster J., et al. Improving resectability and survival in patients with primary duodenal carcinoma. Am J Surg 166 (1993) 626-631
13. Bakaeen F., Murr M., Sarr M., et al. What prognostic factors are important in duodenal adenocarcinoma?. Arch Surg 134 (2000) 635-642
14. Ohigashi H., Ishikawa O., Tamura S., et al. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreatoduodenectomy plus extended lymphadenectomy. Surgery 124 (1998) 510-515
15. Ryder N., Ko C., Hines O., et al. Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg 135 (2000) 1070-1075
16. Sarela A., Brennan M., Karpeh M., et al. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol 11 (2004) 380-386